Hester Biosciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA7374
EBIT5757
Earning Per Share4046
Expenses146175
Net Profit3539
Net Profit Margin1617
Operating Profit Margin3431
Profit Before Tax5053
Dividends Per Share1010
Operation Revenue219249

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Hester Biosciences is 74 as of 2/27/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities3847375824
Investing Activities-26-22-74-38-77
Financing Activities-11319-1842
Others00000
Net Cash Flow128-191-12

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Hester Biosciences is 24 as of 2/27/2024